The United States intravenous solution market size reached US$ 2,927 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,728 Million by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.
Intravenous (IV) solutions are a complete mix of essential nutrients that help to replenish fluid loss, treat electrolyte imbalance and maintain fluid balance in IV therapy. These solutions provide nutrients to patients who have diabetes, cancer, and other such diseases. IV solutions contain water with electrolytes, sugar, or medications added in concentrations according to the patient’s medical condition, age and body size. Furthermore, the manufacturers are coming up with new and innovative products, such as premixed solutions that provide better convenience and reduce packaging wastage.
The United States IV solution market is primarily driven by the growing prevalence of lifestyle diseases and the increasing geriatric population. Besides this, a well-developed healthcare industry, coupled with high per capita healthcare expenditure and the ready availability of IV solutions are also propelling the growth of the market across the country. The rising prevalence of gastrointestinal and neurological diseases is also acting as another major growth-inducing factor. Moreover, IV solutions are available in portable packages, thus making it easy for the patients to use drips from within the comfort of their homes. This, in turn, is creating a positive outlook for the market in the United States.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the United States intravenous solution market report, along with forecasts at the country and region level from 2023-2028. Our report has categorized the market based on type and nutrients.
Breakup by Type:
Breakup by Nutrients:
- Salts and Electrolytes
- Amino Acids
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis
||Partial Parenteral Nutrition, Total Parenteral Nutrition
||Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids
||Northeast, Midwest, South, West
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the United States intravenous solutions market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the United States intravenous solutions market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the nutrients?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the United States intravenous solutions market and who are the key players?
- What is the degree of competition in the industry?